Location Sherborn, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Mike has more than 25 years of experience in healthcare and life sciences. Most recently, he was the founder and CEO of Anchor Therapeutics, a venture-backed company focusing on developing pepducins, a new biology platform for drug discovery.
Prior to founding Anchor, he was the CEO of EPIX Pharmaceuticals, Inc. from 1994 through 2005. During
this period, EPIX grew from a venture-backed startup to the world leader in discovery and development of pharmaceuticals for diagnostic imaging with MRl, achieving worldwide approval for its lead product and completing numerous financings and corporate partnerships including an IPO on NASDAQ.
Mr. Webb joined EPIX from CIBA, where he was most recently Senior Vice President, Worldwide Marketing and Strategic Planning of CIBA Diagnostics, responsible for global marketing, program management, corporate planning, business development and licensing.
Prior to CIBA, Mr. Webb was a senior consultant at Booz, Allen & Hamilton, specializing in healthcare and life sciences.
Mr. Webb holds Bachelors degrees in Biochemistry and Economics from the University of Kansas, Summa Cum Laude and an MA in International Relations from Sussex University in the UK, completing his thesis on "Pharmaceuticals Policy and the World Health Organization." In addition, Mr. Webb holds an MBA degree with honors from the Kellogg Graduate School of Management at Northwestern University.
He is a past chairman of the Massachusetts Biotechnology Council and currently serves on the boards of Anchor and Virtify, where he is Chairman of the Board.
He also serves on the advisory boards of Deuteria Pharmaceuticals, Estern Medical, Wolfe Laboratories, the Kellogg Center for Biotechnology at Northwestern, the Institute for Advancing Medical Innovation at the University of Kansas and is a Senior Advisor to Johnston Blakely, a life sciences investment banking firm.
